Recovery Act Limited Competition: Small Business Catalyst Awards for Accelerating Innovative Research (R43)
National Institute on Drug Abuse Participating
This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 invites grant applications from small business concerns that propose to accelerate innovation through high risk, high reward research and development (R&D) that has commercial potential and is relevant to the mission of the NIH. The Small Business Catalyst Award is further expected to support entrepreneurs of exceptional creativity, drawn from scientific and technological environments beyond NIH, who propose pioneering and possibly transformative approaches to addressing major biomedical or behavioral challenges with the potential for downstream commercial development. The outcomes of the research supported should have potential to lead to products that will improve public health and create significant value and economic stimulus. Specifically, this FOA solicits early-stage ideas that represent advancement in a technological area that promises to lead to major leaps forward, not merely incremental improvements of existing technologies, e.g., projects that have the potential to generate high impact results and/or innovative research applications, research tools, techniques, devices, inventions, or methodologies.
This initiative is one of several being offered by IC to help fulfill the goals of the American Recovery and Reinvestment Act (ARRA) to help stimulate the economy through support of biomedical and behavioral research. Additional information the Recovery Act and related NIH opportunities is available through the Office of Extramural Research http://grants.nih.gov/recovery/
High-risk, high reward R&D that is unlikely to be undertaken by ongoing academic efforts or within industrial firms is strongly encouraged. In addition, NIH encourages technologies stemming from an emerging scientific field or technological capacity that would be beneficial if successfully commercially developed. Applicants that have been supported by other Federal agencies for R&D that draw from the mathematical, computational, physical, behavioral or social sciences are encouraged.
- NIH intends to commit as least $5 million under this FOA.
- 20-25 awards will be made for fiscal year 2010
Budget: Budget requests are limited to $200,000 total costs for a maximum project period of one year.
Eligibility: Only United States small business concerns (SBCs) are eligible to submit SBIR applications
- More than one PD/PI (i.e., multiple PDs/PIs) may be designated on the application. Under the SBIR program, the primary employment of the PD/PI must be with the small business concern at the time of award and during the conduct of the proposed project.
- Resubmissions are not permitted.
- The Research Plan is limited to a total of 7 pages, including 1 page for the Specific Aims and 6 pages for Research Design and Methods.
Letters of Intent Due Date: August 3, 2009
Application Due Date(s): September 1, 2009
Earliest Anticipated Start Date(s): April 2010
Expiration Date: September 2, 2009
Timeline for Review:
Applications will be reviewed by November/December 2009.
Dr. Cathrine Sasek
Grants Management Contact(s):
Ms. Diana Haikalis
Grants Management Specialist